StageZero Life Sciences Ltd.

SZLSF · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
9/30/2023
Operating Activities
Net Income-$399-$649-$385-$822
Dep. & Amort.-$17$44$18$38
Deferred Tax$0$0$0-$179
Stock-Based Comp.$12$12$12$261
Change in WC$315$606$209$679
Other Non-Cash$100-$75$53$70
Operating Cash Flow$10-$63-$93$48
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$65$78$72-$117
Stock Issued$0$0$0$19
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$81$0-$0$10
Financing Cash Flow-$16$78$72-$88
Forex Effect$0$0$2$0
Net Chg. in Cash-$6$15-$18-$40
Supplemental Information
Beg. Cash$21$6$24$64
End Cash$15$21$6$24
Free Cash Flow$10-$63-$93$48